DexCom, Inc. (BMV:DXCM)

Market Cap	464.72B
Revenue (ttm)	82.83B
Net Income (ttm)	13.22B
Shares Out	n/a
EPS (ttm)	32.96
PE Ratio	35.15
Forward PE	26.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15
Average Volume	996
Open	1,168.00
Previous Close	n/a
Day's Range	1,168.00 - 1,168.00
52-Week Range	1,062.55 - 1,795.37
Beta	n/a
RSI	43.23
Earnings Date	Feb 13, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DXCM

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD